Cong Gai

Cong Gai

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2023 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
LLLan Lei
Lan Lei
YWYa-Ting Wang
Ya-Ting Wang
DHDie Hu
Die Hu
CGCong Gai
Cong Gai
YZYi Zhang
Yi Zhang

18 September 2024 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
ZTZijiao Tian
Zijiao Tian
YZYixin Zhang
Yixin Zhang
JXJing Xu
Jing Xu
QYQianwen Yang
Qianwen Yang
DHDie Hu
Die Hu
CGCong Gai
Cong Gai
Primary cilia (PC) are microtubules-based, independent antennal-like sensory organelles, that are seen in most vertebrate cells of different types, including astrocytes and neurons. They send signals to cells to control many physiological and cellular processes by detecting changes in the extracellular environment. Parkinson’s disease (PD), a neurodegenerative disease that progresses over time, is primarily caused by a gradual degradation of the dopaminergic pathway in the striatum nigra, which results in a large loss of neurons in the substantia nigra compact (SNpc) and a depletion of dopamine (DA). PD samples have abnormalities in the structure and function of PC. The alterations contribute to the cause, development, and recovery of PD via influencing signaling pathways (SHH, Wnt, Notch-1, α-syn, and TGFβ), genes (MYH10 and LRRK2), defective mitochondrial function, and substantia nigra dopaminergic neurons. Thus, restoring the normal structure and physiological function of PC and neurons in the brain are effective treatment for PD. This review summarizes the function of PC in neurodegenerative diseases and explores the pathological mechanisms caused by PC alterations in PD, in order to provide references and ideas for future research.

28 April 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
RLRan Liu
Ran Liu
XJXinyan Jiang
Xinyan Jiang
RDRuijuan Dong
Ruijuan Dong
YZYuting Zhang
Yuting Zhang
CGCong Gai
Cong Gai
PWPeng Wei
Peng Wei
Host immune responses to antigens are tightly regulated through the activation and inhibition of synergistic signaling networks that maintain homeostasis. Stimulatory checkpoint molecules initiate attacks on infected or tumor cells, while inhibitory molecules halt the immune response to prevent overreaction and self-injury. Multiple immune checkpoint proteins are grouped into families based on common structural domains or origins, yet the variability within and between these families remains largely unexplored. In this review, we discuss the current understanding of the mechanisms underlying the co-suppressive functions of CTLA-4, PD-1, and other prominent immune checkpoint pathways. Additionally, we examine the IgSF, PVR, TIM, SIRP, and TNF families, including key members such as TIGIT, LAG-3, VISTA, TIM-3, SIRPα, and OX40. We also highlight the unique dual role of VISTA and SIRPα in modulating immune responses under specific conditions, and explore potential immunotherapeutic pathways tailored to the distinct characteristics of different immune checkpoint proteins. These insights into the unique advantages of checkpoint proteins provide new directions for drug discovery, emphasizing that emerging immune checkpoint molecules could serve as targets for novel therapies in cancer, autoimmune diseases, infectious diseases, and transplant rejection.

9 December 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
HZHuimin Zhu
Huimin Zhu
ZLZijian Liu
Zijian Liu
JFJing Feng
Jing Feng
DHDie Hu
Die Hu
XLXia Li
Xia Li
CGCong Gai
Cong Gai
Background: Parkinson's disease (PD) is a neurodegenerative disorder that worsens progressively. Different pathological mechanisms are involved in the progression of PD, including the loss of dopaminergic (DA) neurons and exacerbated oxidative damage in the nigrostriatal path. Da‐Bu‐Yin‐Wan combined with Qian‐Zheng‐San is called Bu‐Yin‐Qian‐Zheng Formula (BYQZF), which is a prescription for PD used in traditional Chinese medicine, but its neuroprotective effects and mechanisms are not well understood. Purpose: The purpose of this study was to explore how BYQZF can activate the Keap1/Nrf2/HO‐1 pathway to effectively lessen oxidative damage, providing insights into its potential anti‐PD effects. Methods: The chemical constituents and pharmacokinetics of BYQZF were analyzed by ultraperformance liquid chromatography in tandem with mass spectrometry (UPLC‐MS/MS). Then, we evaluated the toxicity and safety of BYQZF treatment. After establishing MPTP‐induced PD mouse models and the administration of BYQZF treatment, PD‐like behaviors were assessed through the pole test, rotarod test and open field experiment. DA neuron loss and apoptosis in the nigrostriatal path were detected via immunofluorescence and western blotting analysis. Oxidative stress levels and the dissociation state of Keap1‐Nrf2 in these brain areas were assessed by ELISA, immunofluorescence Co‐IP, RT‐qPCR, and western blot analysis. We constructed Nrf2‐knockdown PD cell models. The transcriptional and Nrf2 protein expression levels were determined using both real‐time quantitative PCR and western blot analysis. We further assessed cellular viability, intracellular ATP content, apoptotic cell ratio, as well as the expression levels of CAT and GSH following MPP + , and BYQZF exposure. Results: The chemical constituents of BYQZF were systematically characterized using UPLC‐MS/MS technology. The results of pharmacokinetic evaluation suggested that the pathological conditions of PD significantly affected the pharmacokinetic behavior of BYQZF in vivo. BYQZF treatment ultimately improved the movement disorders in MPTP‐induced PD mice, by alleviating the damage of dopaminergic neurons within the nigrostriatal path. In addition, BYQZF reduced the damage caused by oxidative stress by decreasing the 8‐OHdG level and increasing the CAT, GSH/GSSG, HO‐1, NQO1, and GCLM levels. Further, BYQZF treatment advanced the dissociation of Keap1 and Nrf2 and the nuclear translocation of Nrf2. Finally, functional experiments by Nrf2‐knockdown PD cell models demonstrated that the neuroprotective effect of BYQZF depends on the integrity of Nrf2, and Nrf2 deficiency significantly weakened its antioxidant and anti‐apoptotic effects. Conclusion: This study elucidated that BYQZF improved PD through the Keap1/Nrf2/HO‐1 signaling pathway and alleviated oxidative stress, which is beneficial for inspiring new strategies for drug development targeting PD.

15 April 2026 in Phytomedicine
Verified
Journal Article
Open access
HZHuimin Zhu
Huimin Zhu
JFJing Feng
Jing Feng
HXHua Xu
Hua Xu
DCDeshan Cai
Deshan Cai
RWRan Wei
Ran Wei
CGCong Gai
Cong Gai
Parkinson's disease (PD) is marked by progressive neurodegeneration and is becoming more widespread across the globe. Da-Bu-Yin-Wan and Qian-Zheng-San (BYQZF) is a compound from Chinese medicine known for its neuroprotective effects, but the specific active ingredients and mechanisms in relation to Parkinson's disease are not clearly comprehended. This investigation aimed to investigate how BYQZF works in treating PD. Behavioral tests, histopathology, and Western blot were used to validate MPTP-induced PD mouse models. Mice were treated with BYQZF or SCFAs. The evaluation included gut microbiota, lipid metabolism and inflammation. To evaluate composition of microbiota, short-chain fatty acids, and canonical inflammatory signaling pathway, methods such as 16S rRNA sequencing, metabolomics, GC-MS, western blotting and RT-qPCR were utilized. The dependency on microbiota was confirmed with a model mimicking germ-free conditions. BYQZF improved motor/non-motor dysfunction, α-syn aggregation, and the decline of dopaminergic neurons in mice with PD, while also alleviating neuroinflammation and oxidative stress. The balance of gut microbiota was restored, SCFAs levels were increased, and the integrity of the intestinal barrier was improved. BYQZF suppressed the activation of the TLR4/MyD88/NF-κB pathway within the microbiota-gut-brain axis, thus decreasing inflammation both systemically and in the nervous system. Supplementation with SCFAs could replicate the aforementioned benefits of BYQZF, whereas depletion of the gut microbiota attenuated its efficacy. BYQZF enriched gut bacteria such as Lachnospiraceae and Ruminococcaceae, which led to increased levels of SCFAs (particularly butyrate) in the serum. This increase was significantly positively correlated with improvements in intestinal barrier function, alleviation of neuroinflammation in the brain, and restoration of movement abilities in PD mice.

7 August 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
YCYifan Chen
Yifan Chen
HWHuizhang Wang
Huizhang Wang
CGCong Gai
Cong Gai
XLXia Li
Xia Li
YLYutong Li
Yutong Li
YTYibo Tang
Yibo Tang
Background: Cordyceps polysaccharides (CSP) have shown neuroprotective potential in models of ischemic stroke, but the underlying mechanisms remain to be clarified. Methods: In this study, the effects of CSP were evaluated in MCAO rats and OGD-exposed BV-2 cells. Results: CSP significantly attenuated ischemic injury and inflammatory responses in both in vivo and in vitro models. Mechanistically, CSP decreased CMPK2 expression, increased TFAM levels, and reduced 8-OHdG expression, suggesting attenuation of oxidative DNA damage and mitochondrial DNA-associated stress. EdU staining further showed that OGD-induced DNA synthesis-related signals were predominantly extranuclear, supporting the possibility of mtDNA-associated alterations under ischemia-like conditions. Moreover, CSP suppressed the upregulation of NLRP3, Caspase-1, N-GSDMD, IL-1β, and IL-18, and reduced LDH release following OGD exposure, suggesting inhibition of inflammasome-associated pyroptotic signaling. Conclusions: These findings suggest that the neuroprotective effects of CSP in ischemic stroke models may be related to the modulation of CMPK2/mtDNA/NLRP3 inflammasome pathway and reduced pyroptosis.